Active Not RecruitingNCT05387837
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
PHASE2 · 50 planned enrolment
- Countries listed
- 1
- Registry update
- May 4, 2025
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE2 · 50 planned enrolment
PHASE1 · 16 planned enrolment